Octave Specialty Group, Inc.
NYSE:OSGInsurance - Specialty
-$0.07 today
- Market cap
- $221.70M
- Beta
- 0.85
- P/E (TTM)
- -1.3
- EPS (TTM)
- -$4.40
Volume 0.29M
Average 0.67M
OSG Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Octave Specialty Group, Inc.NYSE: OSG
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 81.1% from a year ago
Cash & equivalents stood at $93.54M at the end of Q1 FY2026, up 81.1% from a year earlier and up 36.7% from the prior quarter. Over 3 fiscal years it compounded at +31.6% a year.
Context
- Cash & equivalents amounted to 4.1% of total assets at the end of Q1 FY2026, up 3.5 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +81.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 68.44M USD
- Year-over-year change
- +44.8%
- 4-year CAGR
- +41.6%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 68.44M | +44.8% |
| FY2024 | 2024-12-31 | 47.28M | +145.9% |
| FY2023 | 2023-12-31 | 19.22M | -35.9% |
| FY2022 | 2022-12-31 | 30M | +76.5% |
| FY2021 | 2021-12-31 | 17M | — |
Cash & Equivalents vs competitors
How OSG compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +81.1% is the 2nd highest of 11, against a peer median of -12.2%.
- Cash & equivalents amounts to 4.1% of total assets for OSG, versus a peer median of 4.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Apr 2026 | CA$567.97M CAD | +67.0% | +87.3% | 8.8% | |
| Mar 2026 | $156.37M USD | -2.1% | +20.7% | 4.2% | |
| Mar 2026 | $146.61M USD | -14.0% | +14.5% | 6.1% | |
| Mar 2026 | $140.68M USD | -10.5% | +36.1% | 4.4% | |
TWFGTWFG, Inc. Common Stock | Mar 2026 | $124.85M USD | -36.4% | +91.1% | 33.6% |
| Mar 2026 | $103.22M USD | +2382.5% | +193.6% | 5.0% | |
| Mar 2026 | $93.54M USD | +81.1% | +31.6% | 4.1% | |
| Mar 2026 | $72M USD | +14.3% | +2.5% | 3.6% | |
| Mar 2026 | $38.78M USD | -86.0% | +38.5% | 1.0% | |
| Mar 2026 | $37.93M USD | -74.4% | +56.3% | 1.0% | |
| Mar 2026 | $34.83M USD | -57.1% | +19.0% | 0.0% | |
| Peer median (excluding OSG) | — | -12.2% | +37.3% | 4.3% | |
Competitors are the stored peer set for OSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 17M | 30M | 19.22M | 47.28M | 68.44M |
| Short-term Investments | 1.84B | 1.9B | 335.73M | 284.62M | 268.74M |
| Net Receivables | 2.47B | 655M | 220.31M | 418.79M | 597.73M |
| Inventory | (3.21B) | (1.76B) | 0 | 0 | 0 |
| Other Current Assets | 3.12B | 1.65B | (685.67M) | 0 | 0 |
| Total Current Assets | 4.32B | 2.6B | 0 | 898.99M | 1.08B |
| Property, Plant & Equipment (Net) | 23M | 21M | 0 | 18.11M | 0 |
| Goodwill | 46M | 61M | 69.69M | 418.23M | 540.35M |
| Intangible Assets | 362M | 326M | 61.4M | 344.78M | 484.73M |
| Long-term Investments | 5.6B | 3.93B | 0 | 28.29M | 24.97M |
| Tax Assets | 5.68B | 4.29B | 0 | 0 | 0 |
| Other Non-current Assets | (6.01B) | (4.32B) | (131.1M) | 6.35B | 92M |
| Total Non-current Assets | 5.7B | 4.32B | 0 | 7.16B | 1.14B |
| Total Assets | 12.3B | 7.97B | 8.43B | 8.06B | 2.22B |
| Account Payables | 33M | 39M | 29.67M | 53M | 80.56M |
| Short-term Debt | 0 | 0 | 0 | 150M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | (757M) | (631M) | 0 | 0 | 187.18M |
| Other Current Liabilities | 181M | 204M | (36.6M) | 419.2M | 525.21M |
| Total Current Liabilities | 33M | 39M | 0 | 205.56M | 909.84M |
| Long-term Debt | 6.45B | 3.75B | 3.48B | 0 | 117.56M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 70.14M | 65.22M |
| Deferred Revenue (Non-current) | 0 | 0 | 6M | 0 | 0 |
| Other Non-current Liabilities | 131M | 2.9B | 7B | 6.59B | 44.53M |
| Total Non-current Liabilities | 6.45B | 6.65B | 7B | 6.66B | 227.31M |
| Total Liabilities | 11.19B | 6.65B | 7B | 6.86B | 1.14B |
| Common Stock | 0 | 0 | 467K | 489K | 489K |
| Retained Earnings | 726M | 1.25B | 1.25B | 742.19M | 370.43M |
| Accumulated OCI | 58M | (253M) | (160.05M) | (188.44M) | 8.48M |
| Other Stockholders Equity | 0 | 1M | 0 | 0 | 0 |
| Minority Interest | 78M | 73M | 70.04M | 338.62M | 370.38M |
| Total Equity | 1.12B | 1.33B | 1.43B | 1.2B | 1.09B |
| Total Debt | 6.45B | 3.75B | 3.48B | 150M | 117.56M |
| Net Debt | 6.43B | 3.72B | 3.46B | 102.73M | 49.12M |
Octave Specialty Group, Inc.
NYSE:OSG
Intrinsic Alpha fair value
Locked
Current Price
$4.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.